Table 2.
Reports (yr) | Endoscopic biopsy | Resected specimens | Overall | |
Underdiagnosis1 | Overdiagnosis2 | Discrepancy3 | ||
Yoon et al[47], 2006 | Tubular adenoma | 2/41 (4.9) | 2/41 (4.9) | 4/41 (9.8) |
Jung et al[29], 2008 | LGIN | 31/74 (42) | - | - |
HGIN | 36/40 (90) | 2/40 (5) | 38/40 (95) | |
Lee et al[48], 2010 | IN | 114/311 (37) | 41/311 (13) | 155/311 (50) |
Carcinoma | 7/86 (8.1) | 16/86 (19) | 23/86 (26) | |
Total | 121/397 (30) | 57/397 (14) | 178/397 (45) | |
Kato et al[27], 2010 | IN | 255/468 (44) | 4/468 (1.7) | 259/468 (46) |
Underdiagnosis was defined as if endoscopic biopsy showed tubular adenoma/ intraepithelial neoplasia but resected specimens finally led to the diagnosis of adenocarcinoma/carcinoma;
Overdiagnosis was defined as if endoscopic biopsy showed tubular adenoma/intraepithelial neoplasia or adenocarcinoma/carcinoma but resected specimens finally led to the diagnosis of non-neoplastic, reactive, regenerative or tubular adenoma, respectively;
Discrepancy was defined as if endoscopic biopsy does not correspond with resected specimen. This can be calculated using resected specimen as a golden standard. LGIN: Low-grade intraepithelial neoplasia; IN: Intraepithelial neoplasia; HGIN: High-grade intraepithelial neoplasia.